Delivery Order SPE2DB24D3013-SPE2DB24FFGYR
Award Date
8/14/24
Potential Completion Date
8/15/24
Potential Value
$12K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of GEMTESA 75 MG TABLET 90S. The contract has a ceiling value of $12,313.85 and an ultimate completion date of August 5, 2024. The contract is a firm fixed-price delivery order, and there is no set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, such as...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GEMTESA 75 MG TABLET 90S. The delivery order is valued at $8,058.59 and has a completion date of September 25, 2024. It is a firm fixed-price contract and is not set aside for any specific business type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GEMTESA 75 MG TABLET 30S. The contract has a ceiling value of $4,494.91 and a completion date of March 13, 2025. It is a firm fixed-price contract with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of GEMTESA 75 MG TABLET 90S. The firm-fixed-price contract has a ceiling value of $1,020.90 and an ultimate completion date of August 14, 2024. The contract was awarded on August 13, 2024 and does not have a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GEMTESA 75 MG TABLET 90S. The fixed-price, firm-fixed-price contract has a ceiling value of $91,155.13 and an ultimate completion date of August 27, 2024. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, to provide a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GEMTESA 75 MG TABLET 90S. The contract has a firm fixed price of $9,465.39 and a completion date of September 27, 2024. The contract is not set aside under any preference program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug GEMTESA 75 MG TABLET 30S. The contract has a ceiling value of $5,733.64 and runs through October 10, 2024. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GEMTESA 75 MG TABLET 90S. The $6,784.27 firm-fixed-price contract has a completion date of September 20, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a range of medical commodities to military treatment programs and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GEMTESA 75 MG TABLET 90S, a medical product, with a ceiling value of $5,702.40 and a period of performance ending on March 14, 2025. The contract is a Firm Fixed Price, Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, with a ceiling value of $43,318.33 and a completion date of May 16, 2025. The contract is a firm fixed-price delivery order and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract...